The fact that they've waited this long … leads me to believe they will put a higher offer on the table. |
The silence was really deafening, given that everybody cares about one thing _ Guidant. Above all, the future of J&J is dictated by what happens with Guidant. |
The silence was really deafening, given that everybody cares about one thing - Guidant. Above all, the future of J&J is dictated by what happens with Guidant. |
The silence was really deafening, given that everybody cares about one thing – Guidant. Above all, the future of J&J is dictated by what happens with Guidant. |
The thing that comes to mind is that Guidant blinked (in the negotiations). |
The thing that comes to mind is that Guidant blinked. |
This is death by a thousand cuts. Even if they win the preponderance of cases, they are still in the unenviable position of having to defend against literally thousands of cases. |
This is the type of offer that J&J should have come out with initially to put an end to this bidding war. Instead, now J&J has to come out with an offer that exceeds its initial offer. |
We've entered into the surreal as far as I'm concerned with the manner that this has been reached so far. Whether or not it's worth it is a question mark. |
What are they thinking about now? The fact that J&J is silent on that speaks volumes about what they had attempted to do before -- just to get a good price. |
When you make assumptions about a drug at this initial stage they are assumptions that can only be validated years down the road. |